Stacy L Taylor Adaptive Biotechnologies Corp (ADPT) insider trading activity

Stacy L Taylor is SVP and General Counsel of Adaptive Biotechnologies Corp. Currently has a direct ownership of 166,287 shares of ADPT, which is worth approximately $588,655. The most recent transaction as insider was on Mar 05, 2024, when has been sold 13,381 shares (Common Stock) at a price of $3.44 per share, resulting in proceeds of $46,030. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 166K

0% 3M change

19.05% 12M change

Total Value Held $588,655

Stacy L Taylor Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 05 2024	SELL Open market or private sale	$46,030 $3.44 p/Share	13,381 Reduced 7.45%	166,287 Common Stock
Mar 04 2024	BUY Grant, award, or other acquisition	-	39,990 Added 18.21%	179,668 Common Stock
Mar 07 2023	SELL Open market or private sale	$115,128 $8.6 p/Share	13,387 Reduced 8.75%	139,678 Common Stock
Mar 06 2023	SELL Open market or private sale	$47,057 $8.57 p/Share	5,491 Reduced 3.46%	153,065 Common Stock
Mar 06 2023	BUY Grant, award, or other acquisition	-	85,697 Added 35.09%	158,556 Common Stock
Mar 08 2022	SELL Open market or private sale	$27,307 $11.44 p/Share	2,387 Reduced 3.17%	72,859 Common Stock
Mar 07 2022	SELL Open market or private sale	$18,844 $12.01 p/Share	1,569 Reduced 2.04%	75,246 Common Stock

Mar 04 2022	BUY Grant, award, or other acquisition	-	61,779 Added 44.58%	76,815 Common Stock
Dec 22 2021	SELL Open market or private sale	$460,140 $30.0 p/Share	15,338 Reduced 50.5%	15,036 Common Stock
Dec 22 2021	BUY Exercise of conversion of derivative security	$110,127 $7.18 p/Share	15,338 Added 33.55%	30,374 Common Stock
Sep 07 2021	SELL Open market or private sale	$19,800 $40.0 p/Share	495 Reduced 3.19%	15,036 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$3,242 $6.55 p/Share	495 Added 3.09%	15,531 Common Stock
Jun 30 2021	SELL Open market or private sale	$173,931 $41.74 p/Share	4,167 Reduced 21.7%	15,036 Common Stock
Jun 30 2021	BUY Exercise of conversion of derivative security	$63,963 $15.35 p/Share	4,167 Added 17.83%	19,203 Common Stock
Jun 17 2021	SELL Open market or private sale	$166,640 $40.0 p/Share	4,166 Reduced 21.7%	15,036 Common Stock
Jun 17 2021	BUY Exercise of conversion of derivative security	$63,948 $15.35 p/Share	4,166 Added 17.83%	19,202 Common Stock
Apr 30 2021	SELL Open market or private sale	$174,680 $41.93 p/Share	4,166 Reduced 21.7%	15,036 Common Stock
Apr 30 2021	BUY Exercise of conversion of derivative security	$63,948 $15.35 p/Share	4,166 Added 17.83%	19,202 Common Stock
Mar 31 2021	SELL Open market or private sale	$166,680 $40.0 p/Share	4,167 Reduced 21.7%	15,036 Common Stock
Mar 31 2021	BUY Exercise of conversion of derivative security	$63,963 $15.35 p/Share	4,167 Added 17.83%	19,203 Common Stock
Mar 04 2021	BUY Grant, award, or other acquisition	-	13,736 Added 47.74%	15,036 Common Stock
Feb 26 2021	SELL Open market or private sale	$155,897 $55.44 p/Share	2,812 Reduced 68.39%	1,300 Common Stock
Feb 26 2021	BUY Exercise of conversion of derivative security	$20,190 $7.18 p/Share	2,812 Added 40.61%	4,112 Common Stock
Feb 16 2021	SELL Open market or private sale	$1,046,988 $64.43 p/Share	16,250 Reduced 92.59%	1,300 Common Stock
Feb 16 2021	BUY Exercise of conversion of derivative security	$515,287 $31.71 p/Share	16,250 Added 48.08%	17,550 Common Stock

SLT

Stacy L Taylor

SVP and General Counsel

Seattle, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Value

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT

Account